Omega Healthcare Investors Inc. (OHI) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.48	$1.22	+154.2%	—	$328.2M	—
Q1 26	$0.49	$0.48	-2.0%	—	$323M	—
Q4 25	$0.5	$0.53	+6.0%	—	$319.2M	—
Q3 25	$0.45	$0.59	+31.1%	—	$311.6M	—
Q2 25	$0.41	$0.5	+22.0%	—	$282.5M	—
Q1 25	$0.46	$0.41	-10.9%	—	$276.8M	—
Q4 24	$0.41	$0.4	-2.4%	—	$279.3M	—
Q3 24	$0.4	$0.47	+17.5%	—	$276M	—
Q2 24	$0.36	$0.47	+30.6%	—	$252.7M	—
Q1 24	$0.3	$0.3	0.0%	—	$243.3M	—
Q4 23	$0.32	$0.25	-21.9%	—	$239.3M	—
Q3 23	$0.33	$0.37	+12.1%	—	$242M	—
Q2 23	$0.31	$0.25	-19.4%	—	$250.2M	—
Q1 23	$0.28	$0.15	-46.4%	—	$218.2M	—
Q4 22	$0.55	$0.19	-65.5%	—	$144.8M	—
Q3 22	$0.37	$0.43	+16.2%	—	$239.4M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$1.96	—	—	$1.2B	—
FY24	—	$1.57	—	—	$1.1B	—
FY23	—	$1.01	—	—	$949.7M	—
FY22	—	$1.81	—	—	$878.2M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$900.8M	$908.4M	$881.7M	$928.8M	$892.4M	$1.1B	$878.2M	$949.7M	$1.1B	$1.2B
YoY change	+21.1%	+0.84%	-2.94%	+5.35%	-3.92%	+19.1%	-17.4%	+8.14%	+10.7%	+13.2%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	900.8M	908.4M	881.7M	928.8M	892.4M	1.1B	878.2M	949.7M	1.1B	1.2B
Cost of revenue	—	0	0	14.9M	12.3M	12.3M	15.5M	15M	14.6M	14.4M
Gross profit	—	908.4M	881.7M	913.9M	880.1M	1.1B	862.7M	934.7M	1B	1.2B
Gross margin	—	100%	100%	98.4%	98.6%	98.8%	98.2%	98.4%	98.6%	98.8%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	45.9M	47.7M	63.5M	57.9M	59.9M	64.6M	69.4M	81.5M	88M	104.1M
Operating expenses	45.9M	47.7M	63.5M	57.9M	59.9M	64.6M	69.4M	81.5M	88M	104.1M
Operating income	578.1M	558.5M	530.2M	554.3M	452.3M	566.2M	392.3M	489M	659.7M	743.9M
Operating margin	64.2%	61.5%	60.1%	59.7%	50.7%	53.3%	44.7%	51.5%	62.7%	62.5%
Non-operating income, net	-18.3M	-232.6M	-32.3M	-1.8M	-66.5M	84.5M	277.1M	2.2M	-17.2M	95.5M
Pretax income	384.3M	105.9M	296.5M	343.8M	162.3M	416.1M	436.1M	255.6M	420.7M	624.4M
Income tax	1.4M	3.2M	3M	2.8M	4.9M	3.8M	4.6M	6.3M	10.9M	14.7M
Net income	383.4M	104.9M	293.9M	351.9M	163.5M	428.3M	438.8M	248.8M	417.8M	609.5M
Net margin	42.6%	11.5%	33.3%	37.9%	18.3%	40.3%	50%	26.2%	39.7%	51.2%
EBITDA	845.3M	856.8M	811.8M	856.8M	781.3M	907.6M	722.7M	829M	971.1M	1.1B
EPS	1.91	0.51	1.41	1.6	0.7	1.76	1.81	1.01	1.57	1.96
Diluted EPS	1.9	0.51	1.4	1.58	0.7	1.75	1.8	1	1.55	1.94

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	242M	239.3M	243.3M	252.7M	276M	279.3M	276.8M	282.5M	311.6M	319.2M	323M	328.2M
Cost of revenue	3.9M	3.2M	3.8M	3.8M	3.6M	3.4M	3.3M	3.3M	3.5M	4.4M	9M	16.2M
Gross profit	238.1M	236.1M	239.5M	249M	272.5M	275.9M	273.5M	279.3M	308.1M	314.8M	313.9M	312M
Gross margin	98.4%	98.7%	98.4%	98.5%	98.7%	98.8%	98.8%	98.8%	98.9%	98.6%	97.2%	95.1%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	20.3M	18.5M	21.5M	22.1M	21.8M	22.6M	32.1M	23.8M	23.8M	24.5M	26M	42M
Operating expenses	20.3M	18.5M	21.5M	22.1M	21.8M	22.6M	32.1M	23.8M	23.8M	24.5M	26M	42M
Operating income	134.3M	109M	134.9M	166.8M	182.5M	175.4M	156.4M	179.7M	206.1M	201.7M	207.1M	193.2M
Operating margin	55.5%	45.5%	55.5%	66%	66.1%	62.8%	56.5%	63.6%	66.1%	63.2%	64.1%	58.9%
Non-operating income, net	21.5M	12.3M	-5.3M	6.1M	-16.5M	-1.5M	10.4M	20.4M	43.4M	21.3M	2.6M	234.6M
Pretax income	97M	61.8M	71.8M	118.9M	111.4M	118.6M	114.6M	147.2M	191.3M	171.3M	159.9M	379.8M
Income tax	1.8M	4.2M	2.6M	2M	3.3M	3M	3.6M	4.5M	4.5M	2.1M	5.1M	4.6M
Net income	93.9M	56.5M	69.3M	117.1M	114.9M	116.5M	112.1M	140.5M	185M	172M	158.6M	379.7M
Net margin	38.8%	23.6%	28.5%	46.3%	41.6%	41.7%	40.5%	49.7%	59.4%	53.9%	49.1%	115.7%
EBITDA	220.5M	195.8M	214.8M	244.4M	258.7M	253.3M	239.4M	273.9M	305.1M	300.9M	292.3M	267.9M
EPS	0.37	—	0.27	0.46	0.43	0.41	0.34	0.46	0.6	0.55	0.47	1.21
Diluted EPS	0.37	—	0.27	0.45	0.42	0.41	0.33	0.46	0.59	0.55	0.47	1.19

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	—	5.4B	7B	9B	8.3B	7B	6.6B	7.4B	9.8B	—	14.7B
Enterprise value	—	9.9B	11.6B	14.1B	13.3B	12.2B	11.6B	12B	14.1B	—	18.3B
Shares outstanding	191.8M	197.7M	200.3M	213.4M	227.7M	236.9M	236.3M	240.5M	258.1M	291.6M	291.6M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	51.9	24	25.7	50.6	16.4	15	29.6	23.4	—	16.6
P/S	—	5.99	7.98	9.73	9.27	6.6	7.52	7.76	9.29	—	11.7
P/B	—	1.4	1.87	2.08	2.05	1.71	1.74	1.96	2.07	—	2.59
EV/EBITDA	—	11.6	14.3	16.5	17	13.5	16	14.5	14.5	—	16
EV/Sales	—	10.9	13.1	15.2	14.9	11.5	13.2	12.6	13.4	—	14.5
Earnings yield	—	1.93%	4.17%	3.89%	1.98%	6.11%	6.65%	3.37%	4.28%	—	6.03%
FCF yield	—	10.6%	7.09%	6.13%	8.56%	10.3%	9.48%	8.38%	7.67%	—	4.52%
PEG	—	—	—	—	—	—	—	—	—	—	0.1

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	—	100%	100%	98.4%	98.6%	98.8%	98.2%	98.4%	98.6%	98.8%	95.1%
Operating margin	64.2%	61.5%	60.1%	59.7%	50.7%	53.3%	44.7%	51.5%	62.7%	62.5%	61.5%
Net margin	42.6%	11.5%	33.3%	37.9%	18.3%	40.3%	50%	26.2%	39.7%	51.2%	68.1%
ROE	9.1%	2.7%	7.81%	8.12%	4.05%	10.4%	11.5%	6.61%	8.83%	11.2%	16.5%
ROA	4.28%	1.2%	3.42%	3.59%	1.72%	4.44%	4.67%	2.73%	4.22%	6.06%	4.91%
ROIC	6.79%	6.46%	6.33%	5.82%	4.85%	6.01%	4.41%	5.69%	7.1%	7.51%	8.24%
Return on tangible assets	5%	1.4%	4.02%	4.14%	2%	5.14%	5.41%	3.18%	4.85%	6.96%	10.3%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	2.98	2.56	2.06	2.82	3.64	6.53	5.3	7.34	8.03	3.46	0.44
Quick ratio	2.98	2.56	2.06	2.82	3.64	6.53	5.3	7.34	8.03	3.46	5.93
Debt / equity	1.04	1.18	1.21	1.18	1.28	1.28	1.39	1.35	1.02	0.78	0.71
Debt / assets	0.49	0.52	0.53	0.52	0.54	0.55	0.56	0.56	0.49	0.42	0.4
Net debt / EBITDA	5.06	5.24	5.58	5.97	6.41	5.77	6.9	5.58	4.45	3.78	3.42
Interest coverage	3.19	1.48	2.47	2.65	1.73	2.77	2.87	2.09	2.9	3.9	5.34
Effective tax rate	0.37%	3.07%	1.02%	0.83%	3.03%	0.92%	1.05%	2.45%	2.58%	2.36%	1.81%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	4.7	4.59	4.4	4.35	3.92	4.49	3.72	3.95	4.07	4.08	4.25
EPS (basic)	1.91	0.51	1.41	1.6	0.7	1.76	1.81	1.01	1.57	1.96	1.96
EPS (diluted)	1.9	0.51	1.4	1.58	0.7	1.75	1.8	1	1.55	1.94	2.81
Book value per share	22	19.7	18.8	20.3	17.7	17.3	16.1	15.6	18.3	18.7	18
FCF per share	3.26	2.92	2.49	2.59	3.11	3.05	2.65	2.57	2.9	3.01	2.82
Cash per share	0.49	0.43	0.05	0.11	0.72	0.09	1.26	1.84	2.01	0.09	0.13
Capex per share	0	0.17	0.1	0.44	0.07	0	0	0	—	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	0%	3.67%	2.38%	10.1%	1.73%	0.07%	0%	0%	—	—	—
Capex / operating cash flow	0%	10.4%	4.54%	17.1%	3.24%	0.1%	0%	0%	—	—	—
Payout ratio	118.2%	479.1%	179.9%	160.3%	374.4%	148.9%	144.2%	258.8%	164.1%	128%	95.4%
Dividend yield	—	9.23%	7.51%	6.24%	7.4%	9.1%	9.58%	8.73%	7.02%	—	5.83%

Yield

5.83%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.68

ex-dividend Aug 3, 2026

Payout ratio

95%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 3, 2026	$0.68
May 4, 2026	$0.67
Feb 9, 2026	$0.67

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$242M	$239.3M	$243.3M	$252.7M	$276M	$279.3M	$276.8M	$282.5M	$311.6M	$319.2M	$323M	$328.2M
YoY change	+1.09%	+65.2%	+11.5%	+1.02%	+14%	+16.7%	+13.8%	+11.8%	+12.9%	+14.3%	+16.7%	+16.2%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	93.7M	85.9M	10.3M	24.1M	163.5M	20.5M	297.1M	442.8M	518.3M	27M
Receivables	230.6M	276.1M	335.7M	395.3M	232.9M	253.5M	180.3M	223.4M	260.1M	285.9M
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	1.6B	1.5B	1.2B	1.2B	1.4B	1.8B	1.8B	2.3B	2.6B	2.1B
Property, plant & equipment	—	—	—	—	—	—	—	—	—	—
Goodwill & intangibles	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B
Total assets	8.9B	8.8B	8.6B	9.8B	9.5B	9.6B	9.4B	9.1B	9.9B	10B
Accounts payable	—	—	—	—	—	—	—	—	—	—
Short-term debt	190M	290M	313M	125M	101.2M	—	19.2M	20.4M	—	242M
Total current liabilities	550.5M	585.1M	585.2M	437M	382M	276.7M	334.3M	308.2M	328.2M	594.5M
Long-term debt	4.2B	4.3B	4.2B	5B	5.1B	5.3B	5.3B	5B	4.8B	4B
Total liabilities	4.7B	4.9B	4.8B	5.5B	5.5B	5.5B	5.6B	5.4B	5.2B	4.6B
Shareholders' equity	4.2B	3.9B	3.8B	4.3B	4B	4.1B	3.8B	3.8B	4.7B	5.4B
Total debt	4.4B	4.6B	4.5B	5.1B	5.2B	5.3B	5.3B	5.1B	4.8B	4.3B
Net debt	4.3B	4.5B	4.5B	5.1B	5B	5.2B	5B	4.6B	4.3B	4.2B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	554.7M	442.8M	361.8M	35.2M	342.4M	518.3M	368M	734.2M	737.2M	27M	26.1M	39M
Receivables	199.7M	223.4M	223.4M	230.9M	250M	260.1M	275.1M	266.6M	276.2M	285.9M	12.7M	276.1M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	2.2B	2.3B	2.2B	2B	2.4B	2.6B	2.4B	2.8B	2.8B	2.1B	2.3B	2.1B
Property, plant & equipment	—	—	—	—	—	—	—	—	—	—	—	—
Goodwill & intangibles	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B	1.3B
Total assets	9.4B	9.1B	9B	8.8B	9.6B	9.9B	9.7B	10.5B	10.6B	10B	10.2B	10B
Accounts payable	—	—	—	—	—	—	—	—	—	—	—	—
Short-term debt	19.5M	20.4M	20.2M	70.2M	—	—	—	—	—	242M	425M	6M
Total current liabilities	296.2M	308.2M	303.3M	357.6M	313.4M	328.2M	327.5M	357M	357.4M	594.5M	763.2M	353.9M
Long-term debt	5.3B	5B	5B	4.6B	4.9B	4.8B	4.4B	5B	5B	4B	4B	4B
Total liabilities	5.6B	5.4B	5.3B	4.9B	5.2B	5.2B	4.8B	5.4B	5.4B	4.6B	4.8B	4.4B
Shareholders' equity	3.9B	3.8B	3.7B	3.9B	4.4B	4.7B	4.9B	5.2B	5.2B	5.4B	5.5B	5.6B
Total debt	5.3B	5.1B	5B	4.7B	4.9B	4.8B	4.4B	5B	5B	4.3B	4.4B	4B
Net debt	4.7B	4.6B	4.7B	4.6B	4.5B	4.3B	4.1B	4.3B	4.3B	4.2B	4.4B	4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	383.4M	104.9M	293.9M	351.9M	163.5M	428.3M	438.8M	248.8M	417.8M	609.5M
Depreciation & amortization	267.1M	287.6M	281.3M	301.7M	329.9M	342M	332.4M	319.7M	304.6M	325.2M
Stock-based compensation	13.8M	15.2M	16M	15.4M	18.8M	21.4M	27.3M	35.1M	36.7M	44.2M
Change in working capital	-43.1M	-89.4M	-127.9M	-123.9M	-30.1M	-41.8M	15.5M	-15.1M	32.9M	-2.9M
Operating cash flow	606.4M	320M	461.6M	548.6M	475.8M	732.1M	762.8M	551.5M	759.6M	878.6M
Capital expenditure	0	33.3M	21M	93.7M	15.4M	717K	0	0	—	—
Investing cash flow	-215.6M	-45.2M	-213.9M	-36.9M	-82.4M	-269.5M	-25.2M	-249.6M	-251.9M	-38M
Dividends paid	-453.2M	-502.6M	-528.7M	-564.1M	-612.3M	-637.6M	-632.9M	-643.9M	-685.4M	-780.4M
Share repurchases	-733K	-48K	-134K	0	0	0	-142.3M	0	0	—
Financing cash flow	-744.3M	-1.9B	-1.7B	-627.1M	-514.1M	-341.1M	-789.4M	-473.3M	26.3M	-838.3M
Net change in cash	-353.5M	-1.6B	-1.4B	-115.3M	-120.7M	121.5M	-51.9M	-171.5M	534M	2.3M
Free cash flow	624.8M	577.9M	499.4M	553.7M	708.3M	722.1M	625.7M	617.7M	749.4M	878.6M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	93.9M	56.5M	69.3M	117.1M	114.9M	116.5M	112.1M	140.5M	185M	172M	158.6M	379.7M
Depreciation & amortization	80.8M	75.7M	74.6M	74.2M	77.2M	78.6M	79.9M	80.5M	82.1M	82.7M	84.1M	81.8M
Stock-based compensation	8.8M	8.8M	9.2M	9.2M	9.1M	9.2M	15.8M	9.2M	9.3M	9.9M	10.6M	23.5M
Change in working capital	1M	9.1M	-9.3M	10.4M	1.7M	30.1M	-18.5M	28.6M	11.2M	-4.9M	-18.4M	-21.7M
Operating cash flow	177.7M	143.3M	139.1M	205.3M	192.3M	222.9M	188.3M	239.3M	226.7M	230.6M	215.5M	217.7M
Capital expenditure	—	—	—	—	—	—	—	—	—	—	—	—
Investing cash flow	-47.5M	-148.2M	-23.8M	-94.2M	-31.7M	-102.2M	-9.2M	3.5M	-83M	50.6M	-170.1M	146.4M
Dividends paid	-164.5M	-164.6M	-164.8M	-166M	-173.3M	-181.4M	-189.2M	-194.6M	-198.2M	-198.4M	-198.4M	-200M
Share repurchases	0	0	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-41.8M	-389.8M	-186M	-777.7M	268.1M	243.4M	-347.7M	589M	-139.1M	-940.5M	54.3M	-639.1M
Net change in cash	88.4M	-394.7M	-70.7M	-666.6M	428.7M	364.1M	-168.6M	831.7M	4.7M	-659.2M	99.7M	-275.1M
Free cash flow	171M	165M	151.5M	184.1M	184.9M	229M	182M	239.3M	226.7M	230.6M	215.5M	217.7M

Omega Healthcare Investors Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement